logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
23/06/2025
HIMS & HERS fell 7.5% pre-market after Novo Nordisk announced the termination of their partnership with the company.
Latest
4 m ago
Power has been restored to the areas affected by the power outage in Tehran, Iran. Some surrounding cities experienced partial power cuts after being attacked.
5 m ago
After Raymond James upgraded its rating on DoorDash stock to "strong buy", its stock price increased by 3%.
5 m ago
After Raymond James upgraded DoorDash's stock rating to "strong buy," its stock price increased by 3%.
5 m ago
Research shows that patients who use the Novo Nordisk weight loss drug Wegovy in combination with the experimental drug bimagrumab, while maintaining muscle mass effectively while losing weight. The results announced at the annual meeting of the American Diabetes Association in Chicago on Monday showed that patients who took the combination of drugs lost 22.1% of their weight in 48 weeks, with 92.8% of that being a reduction in body fat. It is worth noting that in the group taking only bimagrumab, all weight loss was from fat and lean body weight increased by 2.5%.
6 m ago
Lantu Intelligent: Shareholders' inquiry transfer price is set at 23.2 yuan per share.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.